BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

OnCusp Therapeutics Secures FDA Fast Track Designation for CUSP06 in Platinum-Resistant Ovarian Cancer

OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validat...

February 13, 2025 | News

Thermo Fisher Scientific Introduces Invitrogen™ EVOS™ S1000 for Advanced Spatial Tissue Imaging

Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging System. This advance...

February 13, 2025 | News

PHC Corporation Partners with CCRM to Advance T-Cell Expansion for Cell and Gene Therapies

PHC Corporation has signed a Master Collaboration Agreement with CCRM, a global leader in regenerative medicine and biomanufacturing, to jointly develop pr...

February 12, 2025 | News

Taiwan's Caliway Biopharmaceuticals Reports Groundbreaking Results for CBL-514 in U.S. and Canada Phase 2b Study

Caliway Biopharmaceuticals unveiled the impressive results of its second Phase 2b clinical study (CBL-0205) for CBL-514, the world’s first in...

February 11, 2025 | News

Fresenius Kabi Launches Calcitonin Salmon Injection to Treat Bone Disorders and Hypercalcemia

Fresenius Kabi, an operating company of Fresenius, announced it has introduced Calcitonin Salmon Injection, USP Synthetic, a calcium regulator, for the tre...

February 11, 2025 | News

Pfizer and Astellas Announce Sustained Survival Benefit in Advanced Urothelial Cancer with PADCEV® and KEYTRUDA® Combination

Enfortumab vedotin plus pembrolizumab continues to demonstrate superior efficacy versus chemotherapy in a broad population, reinforcing the combination a...

February 11, 2025 | News

AbbVie Announces FDA Approval of EMBLAVEO™, a Groundbreaking Antibiotic for Complicated Intra-Abdominal Infections

AbbVie announced the U.S. Food and Drug Administration (FDA) approval of EMBLAVEO™ (aztreonam and avibactam), marking a pivotal step in the fight aga...

February 10, 2025 | News

Thermo Fisher Secures FDA Clearance for Multiplex Test Targeting Four Major Respiratory Viruses

Thermo Fisher Scientific has announced the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Applied Biosystems™ TaqPath&trad...

February 10, 2025 | News

Henlius and Dr. Reddy’s Forge Licensing Deal for Daratumumab Biosimilar in U.S. and Europe

Shanghai Henlius Biotech, Inc. announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Redd...

February 07, 2025 | News

BD Splits for Bigger Wins: MedTech Powerhouse and Life Sciences Leader to Emerge

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valu...

February 06, 2025 | News

Thermo Fisher Scientific Launches CorEvitas Adolescent Alopecia Areata Registry to Advance Real-World Research

Thermo Fisher Scientific Inc., the world leader in serving science, announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Reg...

February 06, 2025 | News

Harbour BioMed Secures NMPA Approval for HBM9378/SKB378 and Signs $970M Global Licensing Deal

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel anti...

February 06, 2025 | News

rBIO’s Biosimilar Insulin, R-biolin, Matches Novolin® R in Preclinical Studies; Company Moves Towards 50x Scale-Up and Human Trials

rBIO's biosimilar insulin, R-biolin, achieves bioequivalence to Novo Nordisk Novolin® R in animal studies; company prepares for 50x scale-up and readie...

February 05, 2025 | News

Nuvation Bio Launches Expanded Access Program in the U.S. for Taletrectinib in ROS1+ NSCLC

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, announced it has initiated ...

February 04, 2025 | News

Stay Connected